129 related articles for article (PubMed ID: 8281440)
21. [Expression and assessment of double genes of tyrosine hydroxylase gene and aromatic L-amino acid decarboxylase gene in vitro].
Su Y; Duan CL; Zhao CL; Zhao HY; Xu QY; Yang H
Sheng Li Xue Bao; 2003 Oct; 55(5):583-8. PubMed ID: 14566408
[TBL] [Abstract][Full Text] [Related]
22. Gene expression of aromatic L-amino acid decarboxylase in cultured rat glial cells.
Li XM; Juorio AV; Paterson IA; Walz W; Zhu MY; Boulton AA
J Neurochem; 1992 Sep; 59(3):1172-5. PubMed ID: 1494905
[TBL] [Abstract][Full Text] [Related]
23. Antagonistic actions of renal dopamine and 5-hydroxytryptamine: effects of amine precursors on the cell inward transfer and decarboxylation.
Soares-da-Silva P; Pinto-do-O PC
Br J Pharmacol; 1996 Mar; 117(6):1187-92. PubMed ID: 8882614
[TBL] [Abstract][Full Text] [Related]
24. Aromatic-L-amino-acid decarboxylase activity in mouse pancreatic islets.
Lindström P
Biochim Biophys Acta; 1986 Nov; 884(2):276-81. PubMed ID: 3533158
[TBL] [Abstract][Full Text] [Related]
25. Uptake and decarboxylation of L-3,4-dihydroxyphenylalanine in cultured monkey placenta amniotic epithelial cells.
Elwan MA; Sakuragawa N
Placenta; 2007; 28(2-3):245-8. PubMed ID: 16580727
[TBL] [Abstract][Full Text] [Related]
26. Accurate assay of dopa decarboxylase by preventing nonenzymatic decarboxylation of dopa.
Okuno S; Fujisawa H
Anal Biochem; 1983 Mar; 129(2):412-5. PubMed ID: 6405659
[TBL] [Abstract][Full Text] [Related]
27. The O-methylated derivative of L-DOPA, 3-O-methyl-L-DOPA, fails to inhibit neuronal and non-neuronal aromatic L-amino acid decarboxylase.
Soares-da-Silva P; Parada A; Serrão P
Brain Res; 2000 Apr; 863(1-2):293-7. PubMed ID: 10773222
[TBL] [Abstract][Full Text] [Related]
28. An anomalous side reaction of the Lys303 mutant aromatic L-amino acid decarboxylase unravels the role of the residue in catalysis.
Nishino J; Hayashi H; Ishii S; Kagamiyama H
J Biochem; 1997 Mar; 121(3):604-11. PubMed ID: 9133632
[TBL] [Abstract][Full Text] [Related]
29. Locomotor response to L-DOPA in reserpine-treated rats following central inhibition of aromatic L-amino acid decarboxylase: further evidence for non-dopaminergic actions of L-DOPA and its metabolites.
Alachkar A; Brotchie JM; Jones OT
Neurosci Res; 2010 Sep; 68(1):44-50. PubMed ID: 20542064
[TBL] [Abstract][Full Text] [Related]
30. Enzymatic assay for perfluoro-tagged metabolites of l-DOPA using crude lysate from E. coli transformed with pKKAADCII.
Dingman S; Snyder-Leiby T; Mack DJ; Thomas R; Guo C
Appl Microbiol Biotechnol; 2004 May; 64(4):556-9. PubMed ID: 14634798
[TBL] [Abstract][Full Text] [Related]
31. Enhancing aromatic L-amino acid decarboxylase activity: implications for L-DOPA treatment in Parkinson's disease.
Hadjiconstantinou M; Neff NH
CNS Neurosci Ther; 2008; 14(4):340-51. PubMed ID: 19040557
[TBL] [Abstract][Full Text] [Related]
32. A pathogenic S250F missense mutation results in a mouse model of mild aromatic l-amino acid decarboxylase (AADC) deficiency.
Caine C; Shohat M; Kim JK; Nakanishi K; Homma S; Mosharov EV; Monani UR
Hum Mol Genet; 2017 Nov; 26(22):4406-4415. PubMed ID: 28973165
[TBL] [Abstract][Full Text] [Related]
33. L-deprenyl induces aromatic L-amino acid decarboxylase (AADC) mRNA in the rat substantia nigra and ventral tegmentum. An in situ hybridization study.
Li XM; Juorio AV; Qi J; Boulton AA
Mol Chem Neuropathol; 1998; 35(1-3):149-55. PubMed ID: 10343976
[TBL] [Abstract][Full Text] [Related]
34. Benserazide decreases central AADC activity, extracellular dopamine levels and levodopa decarboxylation in striatum of the rat.
Jonkers N; Sarre S; Ebinger G; Michotte Y
J Neural Transm (Vienna); 2001; 108(5):559-70. PubMed ID: 11459076
[TBL] [Abstract][Full Text] [Related]
35. Absence of decarboxylation of some aromatic-L-amino acids by cultured astrocytes.
Juorio AV; Walz W; Sloley BD
Brain Res; 1987 Nov; 426(1):183-6. PubMed ID: 3121134
[TBL] [Abstract][Full Text] [Related]
36. Localization and functional significance of striatal neurons immunoreactive to aromatic L-amino acid decarboxylase or tyrosine hydroxylase in rat Parkinsonian models.
Lopez-Real A; Rodriguez-Pallares J; Guerra MJ; Labandeira-Garcia JL
Brain Res; 2003 Apr; 969(1-2):135-46. PubMed ID: 12676374
[TBL] [Abstract][Full Text] [Related]
37. SCH 23390 enhances exogenous L-DOPA decarboxylation in nigrostriatal neurons.
Neff NH; Wemlinger TA; Hadjiconstantinou M
J Neural Transm (Vienna); 2000; 107(4):429-43. PubMed ID: 11215754
[TBL] [Abstract][Full Text] [Related]
38. NSD-1015 alters the gene expression of aromatic L-amino acid decarboxylase in rat PC12 pheochromocytoma cells.
Li XM; Juorio AV; Boulton AA
Neurochem Res; 1993 Aug; 18(8):915-9. PubMed ID: 8371833
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of decarboxylase and levels of dopa and 3-O-methyldopa: a comparative study of benserazide versus carbidopa in rodents and of Madopar standard versus Madopar HBS in volunteers.
Da Prada M; Kettler R; Zürcher G; Schaffner R; Haefely WE
Eur Neurol; 1987; 27 Suppl 1():9-20. PubMed ID: 3123242
[TBL] [Abstract][Full Text] [Related]
40. Uptake of L-3,4-dihydroxyphenylalanine and dopamine formation in cultured renal epithelial cells.
Soares-da-Silva P; Vieira-Coelho MA; Serrão MP
Biochem Pharmacol; 1997 Nov; 54(9):1037-46. PubMed ID: 9374425
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
